Application 220437
- Type
- ANDA
- Sponsor
- SANDOZ INC
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 002 | TIVOZANIB | TIVOZANIB | CAPSULE | 1.34MG | No | No |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| FOTIVDA | TIVOZANIB | AVEO Pharmaceuticals, Inc. | de77155c-ecf2-4f15-9758-21d271449d83 | 2025-10-01 | Warnings, Adverse reactions | TIVOZANIB |